Target Name: KRT18P50
NCBI ID: G442236
Other Name(s): keratin 18 pseudogene 50 | Keratin 18 pseudogene 50

KRT18P50: A Potential Drug Target and Biomarker

Keratin is a protein that plays a crucial role in the structure and function of hair and nails. It is composed of several types of proteins, including alpha, beta, gamma, delta, and epsilon, which are responsible for different aspects of the protein. One of the Keratin genes, KRT18P50, has been identified as a potential drug target and biomarker for various diseases, including cancer, diabetes, and neurodegenerative disorders.

The KRT18P50 gene is located on chromosome 16 and encodes a protein that is expressed in most tissues of the body. It is a 18-kDa protein that consists of 251 amino acids. The protein is involved in various cellular processes, including cell signaling, DNA replication, and repair, and is also involved in the formation of the cytoskeleton.

KRT18P50 has been shown to be a potential drug target by its ability to interact with several drug molecules, including inhibitors of the tyrosine kinase pathway, which is a signaling pathway that is involved in many cellular processes, including cell growth, differentiation, and survival. Additionally, the KRT18P50 gene has been shown to be involved in the regulation of cell cycle progression, which is a critical process that is involved in the development and progression of many diseases, including cancer.

In addition to its potential as a drug target, KRT18P50 has also been identified as a potential biomarker for several diseases. For example, it has been shown to be elevated in the blood of patients with multiple myeloma, a type of cancer that is characterized by the production of a large number of malignant plasma cells. Additionally, KRT18P50 has been shown to be elevated in the blood of patients with neurodegenerative disorders, such as Alzheimer's disease and Parkinson's disease.

The discovery of KRT18P50 as a potential drug target and biomarker has important implications for the development of new treatments for a variety of diseases. By targeting the KRT18P50 protein, researchers may be able to develop new therapies that can treat a wide range of conditions, including cancer, diabetes, and neurodegenerative disorders. Additionally, the identification of KRT18P50 as a potential biomarker for diseases has the potential to improve the accuracy and effectiveness of diagnostic tests for these conditions.

In conclusion, KRT18P50 is a protein that has the potential to be a drug target and biomarker for a variety of diseases. Its properties as a protein involved in cell signaling, DNA replication, and repair, as well as its involvement in the regulation of cell cycle progression, make it an attractive target for researchers to investigate. Furthermore, the identification of KRT18P50 as a potential biomarker for diseases has the potential to improve the accuracy and effectiveness of diagnostic tests for these conditions. Further research is needed to fully understand the potential of KRT18P50 as a drug target and biomarker.

Protein Name: Keratin 18 Pseudogene 50

More Common Targets

KRT18P51 | KRT18P55 | KRT18P59 | KRT18P6 | KRT18P62 | KRT19 | KRT19P2 | KRT19P3 | KRT2 | KRT20 | KRT222 | KRT23 | KRT24 | KRT25 | KRT26 | KRT27 | KRT28 | KRT3 | KRT31 | KRT32 | KRT33A | KRT33B | KRT34 | KRT35 | KRT36 | KRT37 | KRT38 | KRT39 | KRT4 | KRT40 | KRT42P | KRT5 | KRT6A | KRT6B | KRT6C | KRT7 | KRT7-AS | KRT71 | KRT72 | KRT73 | KRT73-AS1 | KRT74 | KRT75 | KRT76 | KRT77 | KRT78 | KRT79 | KRT8 | KRT80 | KRT81 | KRT82 | KRT83 | KRT84 | KRT85 | KRT86 | KRT87P | KRT89P | KRT8P10 | KRT8P11 | KRT8P12 | KRT8P14 | KRT8P16 | KRT8P17 | KRT8P18 | KRT8P22 | KRT8P23 | KRT8P25 | KRT8P26 | KRT8P29 | KRT8P3 | KRT8P33 | KRT8P36 | KRT8P37 | KRT8P39 | KRT8P41 | KRT8P44 | KRT8P45 | KRT8P46 | KRT8P47 | KRT8P48 | KRT8P49 | KRT8P5 | KRT8P7 | KRT8P8 | KRT8P9 | KRT9 | KRT90P | KRTAP1-1 | KRTAP1-3 | KRTAP1-4 | KRTAP1-5 | KRTAP10-1 | KRTAP10-10 | KRTAP10-11 | KRTAP10-12 | KRTAP10-2 | KRTAP10-3 | KRTAP10-4 | KRTAP10-5 | KRTAP10-6